Trial
NCT04372927
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
AstraZeneca
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Intervention
Cisplatin
Why stopped
Terminated due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-13